Glaucoma, Angle-Closure: Clinical Trials

3 trials for Glaucoma, Angle-Closure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 unknown. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 1, Terminated 1, Unknown 1

Follow Glaucoma, Angle-Closure: new trials by email Literature Review of Glaucoma, Angle-Closure trials Research Report on Glaucoma, Angle-Closure

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Brimonidine and Timolol Ophthalmic Solution With Latanoprost Compared With Latanoprost in Glaucoma Patients
brimonidine 0.2%/timolol 0.5% fixed combination ophthalmic solution, latanoprost - Glaucoma, Angle-Closure
Phase 4TerminatedAllergan172009-11-012013-02-06
Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG)
Travoprost 0.004% (Travatan), Pilocarpine 1% - Angle-closure Glaucoma
Phase 4CompletedAlcon Research302007-02-012023-12-06
Relationship Between Topiramate Use and Ocular Angle Status
Topiramate - Glaucoma, Angle-Closure
Phase 4UnknownChinese University of Hong Kong152004-09-012007-10-31

Broader conditions

Eye Diseases (3)  ·  Glaucoma (3)  ·  Ocular Hypertension (3)

Interventions

Brimonidine Tartrate (1)  ·  Brimonidine Tartrate, Timolol Maleate Drug Combination (1)  ·  Latanoprost (1)  ·  Timolol (1)  ·  Topiramate (1)  ·  Travoprost (1)

Sponsors

Alcon Research (1)  ·  Allergan (1)  ·  Chinese University of Hong Kong (1)

Countries

Hong Kong (1)  ·  Thailand (1)

Top investigators

Dexter YL Leung, MRCS (1)  ·  Howan Leung, MRCP (1)